Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Browse the full record of transactions filed by Szyman Catherine M., Board Member. Insider active across 4 companies, notably Edwards Lifesciences Corp. Cumulatively, 50 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €527k. Activity tracked since 4 May 2021. The latest transaction was disclosed on 11 March 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Szyman Catherine M.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Szyman Catherine M. is a Board Member, with 50 filings in total. In the recent filings tracked, they cover the period from 2021-05-06 to 2026-03-16, with EUR 527054 of sales and a dominant transaction nature listed as Option exercise. They are linked to Edwards Lifesciences Corp, Inari Medical, Inc., Outset Medical, Inc. and MASIMO CORP.